Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism

American Journal of Respiratory Cell and Molecular Biology

Volumn 53, Issue 1, 2015, Pages 105-112

  Lansley, Sally M ^a   Cheah, Hui Min ^a,b   Della Vergiliana, Julius F Varano ^a   Chakera, Aron ^b,c   Lee, Y C Gary ^a,b,c  

^a Lung Institute of Western Australia   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Effusion; Intrapleural fibrinolytic therapy; Monocyte chemotactic protein 1; Pleural infection; Tissue plasminogen activator

Indexed keywords

CHEMOKINE RECEPTOR CCR2 ANTAGONIST; DEOXYRIBONUCLEASE; GLUCOSE; LACTATE DEHYDROGENASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VASCULOTROPIN; CCL2 PROTEIN, HUMAN; CCL2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOPHIL; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EOSINOPHIL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE; MACROPHAGE; MESOTHELIUM CELL; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PLEURA EFFUSION; PLEURA FLUID; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; ANIMAL; CHEMICALLY INDUCED; METABOLISM; PATHOLOGY; PLEURA CAVITY; TUMOR CELL LINE;

MUS;

ANIMALS; CELL LINE, TUMOR; CHEMOKINE CCL2; FEMALE; HUMANS; MICE; PLEURAL CAVITY; PLEURAL EFFUSION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84936997654     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0017OC     Document Type: Article

References (28)

1. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003;58:ii18-ii28.
2. Strange C, Sahn SA. The definitions and epidemiology of pleural space infection. Semin Respir Infect 1999;14:3-8.
3. Brims FJ, Lansley SM, Waterer GW, Lee YC. Empyema thoracis: new insights into an old disease. Eur Respir Rev 2010;19:220-228.
4. Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA. Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis 1993;147:962-966.
5. Moulton JS, Benkert RE, Weisiger KH, Chambers JA. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase. Chest 1995;108:1252-1259.
6. Jerjes-Sánchez C, Ramirez-Rivera A, Elizalde JJ, Delgado R, Cicero R, Ibarra-Perez C, Arroliga AC, Padua A, Portales A, Villarreal A, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. Chest 1996;109:1514-1519.
7. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 1997;155:291-295.
8. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997;111:275-279.
9. Zhu Z, Hawthorne ML, Guo Y, Drake W, Bilaceroglu S, Misra HL, Light RW. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006;129:1577-1583.
10. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011;365:518-526.
11. Piccolo F, Pitman N, Bhatnagar R, Popowicz N, Smith NA, Brockway B, Nickels R, Burke AJ, McCartney R, Choo-Kang B, et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection: an effective and safe alternative to surgery. Ann Am Thorac Soc 2014;11:1419-1425.
12. Nagamachi Y, Tani M, Shimizu K, Tsuda H, Niitsu Y, Yokota J. Orthotopic growth and metastasis of human non-small cell lung carcinoma cell injected into the pleural cavity of nude mice. Cancer Lett 1998;127:203-209.
13. Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prele CM, Laurent GJ, Mutsaers SE. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 2002;115:1383-1389.
14. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29:313-326.
15. Nasreen N, Mohammed KA, Galffy G, Ward MJ, Antony VB. MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells. Am J Physiol Lung Cell Mol Physiol 2000;278:L591-L598.
16. Milliken D, Scotton C, Raju S, Balkwill F, Wilson J. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin Cancer Res 2002;8:1108-1114.
17. Stathopoulos GT, Psallidas I, Moustaki A, Moschos C, Kollintza A, Karabela S, Porfyridis I, Vassiliou S, Karatza M, Zhou Z, et al. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J Natl Cancer Inst 2008;100:1464-1476.
18. Antony VB. Immunological mechanisms in pleural disease. Eur Respir J 2003;21:539-544.
19. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-550.
20. Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009;41:998-1001.
21. García-Román J, Zentella-Dehesa A. Vascular permeability changes involved in tumor metastasis. Cancer Lett 2013;335:259-269.
22. Sakao Y, Kajikawa O, Martin TR, Nakahara Y, Hadden III WA, Harmon CL, Miller EJ. Association of IL-8 and MCP-1 with the development of reexpansion pulmonary edema in rabbits. Ann Thorac Surg 2001;71:1825-1832.
23. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Protein kinase Ca-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem 2006;281:8379-8388.
24. Wolf MJ, Hoos A, Bauer J, Boettcher S, Knust M, Weber A, Simonavicius N, Schneider C, Lang M, Sturzl M, et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 2012;22:91-105.
25. Goede V, Brogelli L, Ziche M, Augustin HG. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 1999;82:765-770.
26. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96:34-40.
27. Antony VB, Godbey SW, Kunkel SL, Hott JW, Hartman DL, Burdick MD, Strieter RM. Recruitment of inflammatory cells to the pleural space: chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 1993;151:7216-7223.
28. Marazioti A, Kairi CA, Spella M, Giannou AD, Magkouta S, Giopanou I, Papaleonidopoulos V, Kalomenidis I, Snyder LA, Kardamakis D, et al. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion. PLoS One 2013;8:e71207.